BioCryst Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
BCRX Nasdaq 2830 www.biocryst.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioCryst Pharmaceuticals, Inc.

BioCryst Announces Formation of Scientific Advisory Board to Drive Rare Disease Pipeline Innovation and Growth - Oct 5th, 2026 5:00 am
Claude AI Just Bought These 2 Pharma Stocks - Sep 29th, 2026 7:26 am
Is BioCryst’s (BCRX) Newest Approval Bigger Than It Looks? - Sep 23rd, 2026 4:26 am
Biopharma Stock With Layers of Technical Support in Place - Sep 21st, 2026 12:44 pm
BioCryst Eyes $1B Rare-Disease Future Through External Innovation - Sep 18th, 2026 8:01 pm
4 Biotech Stocks to Watch as Potential Takeover Targets - Sep 18th, 2026 10:31 am
BioCryst (BCRX) Turns its First Profit and Now Wants to Go Shopping for Rare Disease Drugs - Sep 17th, 2026 10:06 am
PHVS Stock Rises 10% in a Month: What Is Driving the Rally? - Sep 15th, 2026 7:50 am
BioCryst Pharmaceuticals (BCRX) Could Be 62% Undervalued On Its ORLADEYO Growth Story - Sep 14th, 2026 10:10 am
Sector Update: Healthcare Stocks Softer in Afternoon Trading - Sep 10th, 2026 11:45 am
BCRX Stock Heads For Fifth Straight Day In The Red – RBC Capital Says BioCryst Faces A ‘Challenging Near-Term Outlook’ - Sep 10th, 2026 9:52 am
BioCryst Pharmaceuticals Faces Competitive Pressure in Hereditary Angioedema Treatment, RBC Says - Sep 10th, 2026 9:42 am
BCRX Stock Posts Worst Day In Over 6 Months After PHVS Trial Win In Rare Swelling Disease - Sep 8th, 2026 5:24 pm
CareMed Has Been Selected as a National Pharmacy Partner by BioCryst and Adds Orladeyo® (berotralstat) to Growing Rare Disease Portfolio - Sep 8th, 2026 2:45 pm
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It - Sep 6th, 2026 6:50 am
Billionaire Portfolios: 2 Under-$20 Healthcare Stock Picks - Sep 2nd, 2026 7:15 am
BioCryst to Present at Upcoming Investor Conference - Sep 1st, 2026 5:00 am
Is BioCryst Pharmaceuticals (BCRX) Stock Outpacing Its Medical Peers This Year? - Aug 31st, 2026 7:40 am
BioCryst’s Orladeyo Built The Cash Pile, CEO Gayer Wants To Buy The Next Asset - Aug 28th, 2026 5:40 pm
Wall Street Analysts Think BioCryst (BCRX) Could Surge 108.21%: Read This Before Placing a Bet - Aug 28th, 2026 7:55 am